Crédit Industriel et Commercial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
BPC
MC
DLA
Crédit Industriel et Commercial's MRNA Position: Q2 2026 in Review
Crédit Industriel et Commercial reduced its Moderna (MRNA) stake by 53% in Q2 2026, selling an estimated $657K and leaving 11,348 shares worth $795K. The position accounts for 0.05% of the portfolio, ranked #220.
Crédit Industriel et Commercial first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.22M in Q1 2026. 437 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Crédit Industriel et Commercial held 11,348 shares of Moderna worth $795K as of Q2 2026.
- Crédit Industriel et Commercial sold 12,690 Moderna shares in Q2 2026, an estimated $657K.
- Moderna made up 0.05% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #220 holding.
- Crédit Industriel et Commercial first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
- Crédit Industriel et Commercial's Moderna position peaked at $1.22M in Q1 2026.
- 437 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.